O que GLP-1 e por que ele aumenta a saciedade O GLP-1, ou peptdeo semelhante ao glucagon tipo 1, liberado principalmente aps a alimentao
Initially implemented to help monitor the CV safety of glucose-lowering drugs in patients with T2D, who either had established CVD or were at high risk of CVD, data that emerged from some of these trials started to show benefits
In addition to NAION, there is also evidence to suggest GLP-1 drugs can worsen diabetic eye disease, also known as diabetic retinopathy
Otros son leves y muy similares a los de la semaglutida, como nuseas, diarrea y vmitos
This data informs three key decisions: whether to continue semaglutide at the current dose, taper and maintain, or adjust the programme before moving forward